Market Currents
Osiris Therapeutics (OSIR -5.2%) slips after a flareup with Sanofi over a sudden termination on...
-
Friday, February 10, 2012, 2:37 PM ETOsiris Therapeutics (OSIR -5.2%) slips after a flareup with Sanofi over a sudden termination on an agreement to develop and commercialize Genzyme. Also adding to today's negative sentiment is the decision of JPMorgan to drop coverage on the stock.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
